DEF 14AThe Ballot
Outlook Therapeutics, Inc. files DEF 14A
Filed Feb 8, 2024 · 2y ago · Accession 0001104659-24-011916
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- DEF 14A
- Filing date
- Feb 8, 2024
- Report date
- Mar 7, 2024
- Document
- tm242558-2_def14a.htm
- Size
- 2.1 MB